[1]

[2]

Chiang CY, Islam T, Xu CH, Chinnayah T, Garfin AMC, Rahevar K, et al. The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region. Eur Respir J 2020;56(4):2003054. https://erj.ersjournals.com/content/56/4/2003054.https://erj.ersjournals.com/content/56/4/2003054

[3]

Huang F, Xia YY, Chen H, Wang N, Du X, Chen W, et al. The impact of the COVID-19 epidemic on tuberculosis control in China. Lancet Reg Health West Pac 2020;3:100032. https://www.sciencedirect.com/science/article/pii/S2666606520300328.https://www.sciencedirect.com/science/article/pii/S2666606520300328

[4]

Komiya K, Yamasue M, Takahashi O, Hiramatsu K, Kadota JI, Kato S. The COVID-19 pandemic and the true incidence of tuberculosis in Japan. J Infect 2020;81(3):e24–5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338857/.ttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338857/

[5]

Xu CH, Li T, Hu DM, Zhang H, Zhao YL, Liu JJ. Predicted impact of the COVID-19 responses on deaths of tuberculosis-China, 2020. China CDC Wkly 2021;3(2):21–4. https://pubmed.ncbi.nlm.nih.gov/34594898/.https://pubmed.ncbi.nlm.nih.gov/34594898/

[6]

[7]

Acuña-Villaorduña C, Jones-López EC, Fregona G, Marques-Rodriguez P, Geadas C, Hadad DJ, et al. Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. Eur Respir J 2018;51(1):1701578. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719538/.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719538/

[8]

Feng ZX, Xiao DC, Jia HY, Feng LJ, Jia SX, Zhu L, et al. Clinical characteristics of 731 students with active tuberculosis (TB) in Puyang City, Henan province. J Clin Pulm Med 2020;25(3):427–30. https://d.wanfangdata.com.cn/periodical/lcfkzz202003023. (In Chinese). https://d.wanfangdata.com.cn/periodical/lcfkzz202003023